Significantly elevated systemic levels after occlusive application of topical tacrolimus in atopic dermatitis [2]

Dermatology

Volumn 212, Issue 3, 2006, Pages 260-261

  Beyeler, Mirjam ^a   Schmid Grendelmeier, Peter ^a   Hafner, Jürg ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Blood level; Occlusive application; Topical tacrolimus

Indexed keywords

PREDNISOLONE; STEROID; TRIAMCINOLONE; TRICLOSAN; TSUKUBAENOLIDE;

ADULT; ATOPIC DERMATITIS; BANDAGE; CASE REPORT; CLINICAL FEATURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LETTER; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; DERMATITIS, ATOPIC; DRUG COMBINATIONS; FEMALE; GELATIN; GLYCEROL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; OCCLUSIVE DRESSINGS; OINTMENTS; TACROLIMUS; ZINC COMPOUNDS;

EID: 33645238950     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091256     Document Type: Letter

References (7)

1. Hultsch T, Kapp A, Spergel J: Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis. Dermatology 2005;211:174-187.
2. Ruzicka T, Bieber T, Schopf E, Rubins A, Dobozy A, Bos JD, Jablonska S, Ahmed I, Thestrup-Pedersen K, Daniel F, Finzi A, Reitamo S: A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med 1997;337:816-821.
3. Kawashima M, Nakagawa H, Ohtsuki M, Tamaki K, Ishibashi Y: Tacrolimus concentrations in blood during topical treatment of atopic dermatitis. Lancet 1996;348:1240-1241.
4. Allen A, Siegfried E, Silverman R, Williams ML, Elias PM, Szabo SK, Korman NJ: Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. Arch Dermatol 2001;137:747-750.
5. Plosker GL, Foster RH: Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation. Drugs 2000;59:323-389.
6. Jusko WJ, Thomson AW, Fung J, McMaster P, Wong SH, Zylber-Katz E, Christians U, Winkler M, Fitzsimmons WE, Lieberman R, et al: Consensus document: therapeutic monitoring of tacrolimus (FK-506). Ther Drug Monit 1995;17:606-614.
7. Rubins A, Gutmane R, Valdmane N, Stevenson P, Foster C, Undre N: Pharmacokinetics of 0.1% tacrolimus ointment after first and repeated application to adults with moderate to severe atopic dermatitis. J Invest Dermatol 2005;125:68-71.